MRKR vs NUE · rev $751.7K vs P/E 25, rev $19.89B
Marker Therapeutics Inc (MRKR) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
MRKR currently screens at market cap $25.3M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the MRKR and NUE stock pages for the full models.
Not investment advice.